Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1088 participants.
Also called NCT07756398
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 1,088 participants
- Registry
-
NCT07756398
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07756398. Randomized; single masking; primary purpose screening. Start 2026-12-15 (anticipated); primary completion 2028-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)
- Acronym
- IMPROVE
- Condition
- Valvular Heart Disease Patients
- Condition
- Aortic Stenosis
- Condition
- Mitral Regurgitation
- Condition
- Left Ventricular Diastolic Dysfunction
- Intervention (Device)
- Kosmos Torso-One AI-guided Point-of-Care Ultrasound (EchoNous, Inc.)
- Lead sponsor
- University of Texas Southwestern Medical Center
Record details
- Record id
cardio:ct-nct07756398- Content hash
c5a388533b0db95f8967b2e17a72fbd609112f49f3caf04f92c260680b2fb625